Lack of evidence for GDF11 as a rejuvenator of aged skeletal muscle satellite cells

por Hinken, Aaron C., Powers, Janine M., Luo, Guizhen, Holt, Jason A., Billin, Andrew N., Russell, Alan J.
Publicado 2016

Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancer

por Xiang, Hong, Chan, Abigael G., Ahene, Ago, Bellovin, David I., Deng, Rong, Hsu, Amy W., Jeffry, Ursula, Palencia, Servando, Powers, Janine, Zanghi, James, Collins, Helen
Publicado 2021

Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma

por Catenacci, Daniel V.T., Rasco, Drew, Lee, Jeeyun, Rha, Sun Young, Lee, Keun-Wook, Bang, Yung Jue, Bendell, Johanna, Enzinger, Peter, Marina, Neyssa, Xiang, Hong, Deng, Wei, Powers, Janine, Wainberg, Zev A.
Publicado 2020